All Stories

  1. Phenotypic Heterogeneity of Movement Behaviors and Its Association With Cardiometabolic Health Using Data From the ORISCAV-LUX 2 Study
  2. Psychosocial burden in type 1 diabetes: a cross-sectional network analysis in the SFDT1 study
  3. Severity of complications is associated with impaired health‐related quality of life in people with type 1 diabetes
  4. Time below range alone is insufficient to identify severe hypoglycaemia risk in type 1 diabetes—the critical role of hypoglycaemia awareness: results from the SFDT1 study
  5. Role of the exposome in mental disorders: a scoping review protocol
  6. Impact of the Exposome in Type 1 Diabetes: Protocol for a Scoping Review
  7. Long COVID Companion-App: Entwicklung eines digitalen Gesundheitswerkzeuges zur Unterstützung von Personen mit Long COVID
  8. Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study
  9. Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort
  10. Sex-specific progression of Parkinson's disease: A longitudinal mixed-models analysis
  11. Impact of the Exposome in Type 1 Diabetes: Protocol for a Scoping Review (Preprint)
  12. Clinical phenotyping of people living with type 1 diabetes according to their levels of diabetes-related distress: results from the SFDT1 cohort
  13. Readiness of adults with type 1 diabetes and diabetes caregivers for diabetes distress monitoring using a voice-based digital health solution: insights from the PsyVoice mixed methods study
  14. The effect of automated insulin delivery system use on diabetes distress in people with type 1 diabetes and their caregivers: A systematic review and meta‐analysis
  15. A voice-based algorithm can predict type 2 diabetes status in USA adults: Findings from the Colive Voice study
  16. Fear of hypoglycemia and sleep in children with type 1 diabetes and their parents
  17. Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1
  18. The transformative role of artificial intelligence in diabetes care and research
  19. Understanding unexpectedly stable trajectories of functional mobility in people with Parkinson’s disease: A mixed methods study
  20. Progression of GBA1 Gaucher-related and Parkinson’s-risk variants: A longitudinal mixed model analysis
  21. Heterogeneity of glycaemic phenotypes in type 1 diabetes
  22. Creation of a pandemic memory by tracing COVID-19 infections and immunity in Luxembourg (CON-VINCE)
  23. Co-design of a voice-based app to monitor long COVID symptoms with its end-users: A mixed-method study
  24. Luxembourg Parkinson’s study -comprehensive baseline analysis of Parkinson’s disease and atypical parkinsonism
  25. Sex-specific progression of Parkinson’s disease: A longitudinal mixed-models analysis
  26. Sex-specific progression of Parkinson’s disease: A longitudinal mixed-models analysis
  27. Mixed-methods study protocol to identify expectations of people with type 1 diabetes and their caregivers about voice-based digital health solutions to support the management of diabetes distress: the PsyVoice study
  28. Validation of a Parkinson's disease questionnaire-39-based functional mobility composite score (FMCS) in people with Parkinson's disease
  29. Co-Design of a Voice-Based Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 (UpcomingVoice Study): Protocol for a Mixed Methods Study
  30. Substituting device-measured sedentary time with alternative 24-hour movement behaviours: compositional associations with adiposity and cardiometabolic risk in the ORISCAV-LUX 2 study
  31. Association between use of psychotropic medications prior to SARS-COV-2 infection and trajectories of COVID-19 recovery: Findings from the prospective Predi-COVID cohort study
  32. Co-Design of a Voice-Based Digital Health Solution to Monitor Persisting Symptoms Related to COVID-19 (UpcomingVoice Study): Protocol for a Mixed Methods Study (Preprint)
  33. Machine learning for predicting neurodegenerative diseases in the general older population: a cohort study
  34. Device-measured physical activity and sedentary time in a national sample of Luxembourg residents: the ORISCAV-LUX 2 study
  35. Associations Between Wearable-Specific Indicators of Physical Activity Behaviour and Insulin Sensitivity and Glycated Haemoglobin in the General Population: Results from the ORISCAV-LUX 2 Study
  36. Recommendations for Successful Implementation of the Use of Vocal Biomarkers for Remote Monitoring of COVID-19 and Long COVID in Clinical Practice and Research
  37. Discovery and Analytical Validation of a Vocal Biomarker to Monitor Anosmia and Ageusia in Patients With COVID-19: Cross-sectional Study
  38. 6Développement de nouveaux ”endpoints” cliniques à l'aide de biomarqueurs numériques basés sur la voix pour le suivi à distance, en vie réelle, de patients en recherche clinique: exemple de biomarqueurs vocaux pour le suivi du statut symptomatique de p...
  39. Vocal biomarker predicts fatigue in people with COVID-19: results from the prospective Predi-COVID cohort study
  40. A voice-based biomarker for monitoring symptom resolution in adults with COVID-19: Findings from the prospective Predi-COVID cohort study
  41. Global diabetes burden: analysis of regional differences to improve diabetes care
  42. Validation of a Parkinson’s Disease Questionnaire-39-based Functional Mobility Composite Score (FMCS) in people with Parkinson’s disease.
  43. The Nutri-Score nutrition label
  44. Use of vocal biomarkers for remote monitoring of Covid-19 and Long Covid in clinical practice and research: recommendations for successful implementation (Preprint)
  45. Intermittent Scanning Glucose Monitoring or Predicted Low Suspend Pump Treatment: Does It Impact Time in Glucose Target and Treatment Preference? The QUEST Randomized Crossover Study
  46. Associations between physical activity prior to infection and COVID-19 disease severity and symptoms: results from the prospective Predi-COVID cohort study
  47. Development of a vocal biomarker for fatigue monitoring in people with COVID-19
  48. Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study
  49. Association between Dietary Factors and Constipation in Adults Living in Luxembourg and Taking Part in the ORISCAV-LUX 2 Survey
  50. Methods to Generate Innovative Research Ideas and Improve Patient and Public Involvement in Modern Epidemiological Research: Review, Patient Viewpoint, and Guidelines for Implementation of a Digital Cohort Study
  51. Unraveling the concepts of distress, burnout, and depression in type 1 diabetes: A scoping review
  52. Digital Health Interventions among People Living with Frailty: A Scoping Review
  53. Towards precision cardiometabolic prevention: results from a machine learning, semi-supervised clustering approach in the nationwide population-based ORISCAV-LUX 2 study
  54. Type 2 diabetes and its characteristics are associated with poor oral health: findings from 60,590 senior women from the E3N study
  55. Intricate relationships between frailty and diabetes: where do we go from here?
  56. Methods to Generate Innovative Research Ideas and Improve Patient and Public Involvement in Modern Epidemiological Research: Review, Patient Viewpoint, and Guidelines for Implementation of a Digital Cohort Study (Preprint)
  57. Identifying hotspots of cardiometabolic outcomes based on a Bayesian approach: The example of Chile
  58. Digital Health Strategies to Fight COVID-19 Worldwide: Challenges, Recommendations, and a Call for Papers
  59. Parkinson’s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions
  60. Prevalence of SARS-CoV-2 infection in the Luxembourgish population: the CON-VINCE study.
  61. Digital Health Strategies to Fight COVID-19 Worldwide: Challenges, Recommendations, and a Call for Papers (Preprint)
  62. Multi-Scale Multivariate Models for Small Area Health Survey Data: A Chilean Example
  63. Diabetes can accelerate frailty progression in older people
  64. Challenges and benefits of integrating diverse sampling strategies in the observation of cardiovascular risk factors (ORISCAV-LUX 2) study
  65. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study
  66. Multiplicative effect of mild depressive symptoms with diabetes on other chronic conditions
  67. Comparative analysis of the association between 35 frailty scores and cardiovascular events, cancer, and total mortality in an elderly general population in England: An observational study
  68. Agreement Between 35 Published Frailty Scores in the General Population
  69. Abstract P011: Predictive Ability of 35 Frailty Scores for Cardiovascular Events in the General Population
  70. Mortality prediction of 35 frailty scores in a 7-years follow-up study in elderly general population
  71. Polluants organiques persistants et contaminants associés au plastique et risque d’obésité : revue systématique
  72. Assessment of body-image perception and attitudes in obesity
  73. A Randomized Controlled Study of Virtual Reality Exposure Therapy and Cognitive-Behaviour Therapy in Panic Disorder with Agoraphobia
  74. Incidencia de displasia broncopulmonar: Incidence